18F-FDG
Commercial- Indications
- Cancer
Company intelligence / Profile preview
Singapore Radiopharmaceuticals is the leading GMP-compliant radiopharmaceutical manufacturer in Singapore, operating the only local cyclotron capable of producing a wide range of PET and SPECT isotopes. The company supplies over ten clinical tracers for diagnostic and research use, supports clinical trials with advanced tracers for therapy response evaluation, and offers custom radiolabelling services for peptides, antibodies, and small molecules. It has established collaborations with academic institutions such as NTU and A*STAR[1][4].
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Singapore Radiopharmaceuticals.